2003
DOI: 10.1136/bjo.87.2.216
|View full text |Cite
|
Sign up to set email alerts
|

Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings

Abstract: Aims: To report on the use of trypan blue (TB) 0.06% for staining the internal limiting membrane (ILM) and epiretinal membrane (ERM) during vitrectomy and report on their histology. Method: 14 consecutive patients with idiopathic macular hole or macular pucker (seven patients each) were prospectively recruited for ILM or ERM peel respectively. After pars plana vitrectomy and induction of posterior vitreous detachment, 0.5 ml TB 0.06% in phosphate buffered saline (VisonBlue) was injected over the posterior pole… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
90
2
8

Year Published

2004
2004
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 167 publications
(107 citation statements)
references
References 17 publications
6
90
2
8
Order By: Relevance
“…Histologically, the appearances of the ERM peeled were comparable to specimens removed in other studies. 16,17 The ERM specimens also showed resemblance in their histological and immunocytochemical characteristics with PHM specimens obtained in a previous study. 7,18 They both contain type IV collagen and GFAP-positive cells.…”
Section: Discussionsupporting
confidence: 60%
“…Histologically, the appearances of the ERM peeled were comparable to specimens removed in other studies. 16,17 The ERM specimens also showed resemblance in their histological and immunocytochemical characteristics with PHM specimens obtained in a previous study. 7,18 They both contain type IV collagen and GFAP-positive cells.…”
Section: Discussionsupporting
confidence: 60%
“…No peroperative or postoperative complications were described. 1,3 Follow-up after 3-4 months showed visual outcomes comparable to those without staining and did not reveal any adverse reactions related to dye use. 1,3 However, there are no studies regarding the effects of trypan blue in the longer term as yet.…”
Section: Commentmentioning
confidence: 73%
“…Imatinib mesylate (Gleevec; Novartis Pharmaceuticals, East Hanover, NJ, USA) is a selective inhibitor of the bcr-abl, c-kit, and platelet-derived growth factor receptor tryrosine kinases and is a promising new targeted therapy for patients with chronic myelogenous leukaemia and gastrointestinal stromal tumours. [1][2][3][4][5] Imatinib mesylate is generally well tolerated, with frequent but mild side effects. Reported side effects include myalgia, fatigue, nausea, dyspepsia, diarrhoea, oedema, and liver-function abnormalities.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…( In this case of post-traumatic cataract with subluxation, the dye was noted to enter the vitreous cavity through clinically evident and nonevident areas of zonular loss. Although Trypan blue at a concentration of 0.06% with exposure time of 2 min has not been found to cause retinal toxicity, [3][4][5] prolonged dye exposure has been reported to be toxic to the retina. In this case, the dye remained in the vitreous for 4 days thereby resulting in toxicity.…”
Section: Case Reportmentioning
confidence: 97%